In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines. (Record no. 9885467)

MARC details
000 -LEADER
fixed length control field 01397 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513162213.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199902s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0344-5704
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s002800050871
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wagner, M M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990208
245 00 - TITLE STATEMENT
Title In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer chemotherapy and pharmacology
Date of publication, distribution, etc. 1999
300 ## - PHYSICAL DESCRIPTION
Extent 115-25 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Cycle
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Division
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colony-Forming Units Assay
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Depsipeptides
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Multiple
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Flow Cytometry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactams
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactones
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Microscopy, Fluorescence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Structure
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Paul, D C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shih, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jordan, M A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wilson, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Williams, D C
773 0# - HOST ITEM ENTRY
Title Cancer chemotherapy and pharmacology
Related parts vol. 43
-- no. 2
-- p. 115-25
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s002800050871">https://doi.org/10.1007/s002800050871</a>
Public note Available from publisher's website

No items available.